Sung-Sun Cho
Director Ejecutivo en YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. .
Cargos activos de Sung-Sun Cho
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - |
Historial de carrera de Sung-Sun Cho
Antiguos cargos conocidos de Sung-Sun Cho.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
ProCell Therapeutics, Inc.
 ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Director Ejecutivo | - | - |
Estadísticas
Internacional
| Corea del Sur | 3 |
Operativa
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| YUANTA 4 SPECIAL PURPOSE ACQUISITION CO., LTD. | Finance |
| Empresas privadas | 1 |
|---|---|
ProCell Therapeutics, Inc.
ProCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ProCell Therapeutics, Inc. develops protein-based therapeutics. It handles the research and development of biotherapeutics capable of entering cells through proprietary Macromolecule Intracellcellular Transduction Technologies (MITT) using a line-up of Macromolecule Transduction Domain (MTD). The company was founded on December 12, 2005 and is headquartered in Seoul, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Sung-Sun Cho
- Experiencia
